naltrexone and Pruritus

naltrexone has been researched along with Pruritus in 98 studies

Research

Studies (98)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (4.08)	18.7374
1990's	17 (17.35)	18.2507
2000's	42 (42.86)	29.6817
2010's	32 (32.65)	24.3611
2020's	3 (3.06)	2.80

Authors

Authors	Studies
Cowan, A; Dun, NJ; Inan, S	4
Bunker, CB; Timoney, L	1
De Mattos, T; Fernandes, LSA; Melo, DF; Nunes, BEM; Tortelly, VD	1
Murray-Brown, FL	1
Andoh, T; Li, S; Maki, T; Uta, D	1
Afshari, K; Daneshpazhooh, M; Dehpour, AR; Foroutan, A; Haddadi, NS; Ostadhadi, S; Shakiba, S	1
Guitart, J; Martinez-Escala, ME; Serrano, L; Zhou, XA	1
Elston, DM; Lee, B	1
Olszewska, M; Rakowska, A; Rudnicka, L; Sikora, M	1
Barnes, M; Montana, S; Patel, P; Sharma, P; Singh, R; Thakker, M	1
Chen, ZF; Ginosar, Y; Hincker, A; Liu, XY; Yazdi, J	1
Kremer, AE; Mettang, T	1
Aldrich, JV; Cowan, A; Dimattio, KM; Liu-Chen, LY; Yakovleva, TV	1
Ständer, S; Zeidler, C	1
Dörfler, A; Forster, C; Handwerker, HO; Vierow, V; Vogelgsang, R	1
Carvalho, B; Nathan, E; Ng, L; Paech, M; Sia, A; Sng, B	1
Chia, BK; Tey, HL	1
Cowan, A; Inan, S; Kehner, GB	1
Harlos, MS; Hohl, CM; Wong, JK	1
Aubé, J; Bohn, LM; Frankowski, KJ; Morgenweck, J; Prisinzano, TE	1
Mittal, A	1
Kim, DK; Kim, H; Kim, HJ; Kim, JJ; Kim, KM; Kim, S; Kim, SY; Koh, JY; Lee, CH; Lee, S; Noh, MS; Park, SH	1
Fantegrossi, WE; Galuska, CM; Ko, MC; Prinssen, EP; Wichmann, J; Woods, JH	1
Akiyama, T; Carstens, E; Carstens, MI; Merrill, AW; Zanotto, K	1
Fujii, M; Fukuno, S; Kohno, S; Mizutani, N; Nabe, T; Nakamura, T	1
Arbabi, M; Jaberian, M; Malekzad, F; Mohajer, M; Mohammadi, MR; Mohtasham, N; Nasiri, S; Roodsari, MR; Toosi, P	1
Andoh, T; Kuraishi, Y; Saito, A	1
Bernhard, JD; Luger, TA; Phan, NQ; Ständer, S	1
Akiyama, T; Carstens, E; Carstens, MI	2
Roy, A; Schwarz, KB; Zellos, A	1
Hojsak, I; Mozer-Glassberg, Y; Shamir, R; Shapiro, R; Zevit, N	1
Hagemann, TM; Miller, JL	1
Abramovits, W; Draelos, Z; Duffy, M; Fleischer, A; Green, E; Herzog, JL; Rothaul, A; Solomon, JA; Stough, D; Tansley, R; Werschler, W; Wolf, DI	1
Benedek, G; Farkas, I; Horvath, G; Joo, G; Kekesi, G; Petrovszki, Z; Tuboly, G	1
Akiyama, T; Carstens, E; Carstens, MI; Cevikbas, F; Ikoma, A; Steinhoff, M	1
Carstens, E; Carstens, MI; Davoodi, A; Spradley, JM	2
Andoh, T; Kuraishi, Y; Lee, JB; Yoshida, T	1
Bailey, A; Garg, N; Kumar, N	1
Alscher, DM; Mettang, T; Pauli-Magnus, C	1
Groene, D; Heyer, G; Martus, P	1
Kuraishi, Y; Maekawa, T; Nojima, H; Yamaguchi-Miyamoto, T	1
Coronel, E; Findor, J; Muñoz, AE; Sordá, J; Terg, R	1
Kishioka, S; Ko, MC; Lee, H; Mosberg, HI; Naughton, NN; Sobczyk-Kojiro, K; Song, MS; Woods, JH	1
Carstens, E; Nojima, H	1
Honda, T; Nagase, H; Nakao, K; Okano, K; Tanaka, T; Togashi, Y; Umeuchi, H	1
Carstens, E; Carstens, MI; Cuellar, JM; Moore, JA; Nojima, H; Simons, CT	1
Clèdes, J; Legroux-Crespel, E; Misery, L	1
Brune, A; Luger, TA; Metze, D; Ständer, S	1
Ajayi, AA; Kolawole, BA; Udoh, SJ	1
Greiner, A; Hebestreit, H; Jeschke, R; Kullak-Ublick, GA; Kunzmann, S	1
Aoki, CA; Gershwin, ME; Itoh, M; Kato, T; Kawashima, Y; Kikuchi, K; Kurokawa, T; Miyakawa, H; Nakao, K; Okano, K; Umeuchi, H	1
Akai, M; Danda, Y; Gellert, R; Ide, K; Kawashima, Y; Ladefoged, SD; Mori, A; Ogasawara, M; Ueno, K; Ueno, Y; Wikström, B	1
Cohen, PD; Ingber, S	1
Bagherzadeh, AH; Ebrahimi-Dariani, N; Farahvash, MJ; Farhangi, E; Froutan, H; Ghofrani, H; Mansour-Ghanaei, F; Mirmomen, S; Nasiri-Toosi, M; Pourrasouli, Z; Taheri, A	1
Cho, SA; Kim, DK; Kim, H; Kim, HJ; Kim, JJ; Kim, KM; Lee, CH; Sung, KS	1
Bigliardi, PL; Bigliardi-Qi, M; Büchner, S; Jost, G; Rufli, T; Stammer, H	1
Han, ES; Kim, H; Kim, HJ; Kim, JJ; Kim, KM; Koh, JY; Lee, CH; Noh, MS; Park, SM	1
LaSalle, L; Nedelec, B; Rachelska, G	1
Schwartz, S	1
Carson, KL; Cotton, P; Hunt, CM; Sharara, AI; Tran, TT	1
Agami, O; Blum, M; Fireman, E; Kivity, S; laina, A; Peer, G; Silverberg, D	1
Bertolotti, M; Hop, WC; Sternieri, E; Van Buuren, HR; Vitale, G; Wolfhagen, FH	1
Diepgen, LT; Dotzer, M; Handwerker, OH; Heyer, G	1
Sullivan, JR; Watson, A	1
Alling, DW; Bergasa, NV; Jenkins, JB; Jones, EA; Schmitt, JM; Swain, MG; Talbot, TL; Turner, ML	1
Sapey, T	1
Heyer, GR; Hornstein, OP	1
Chehade, J; Duffy, L; Gajraj, N; Johnson, ER; Joshi, GP; Wesevich, J	1
Alling, DW; Bergasa, NV; Jones, EA; Talbot, TL; Wells, MC	1
Beissert, S; Luger, T; Metze, D; Reimann, S	1
Dekker, LR; Jones, EA	1
Ajayi, AA; Onigbogi, O; Ukponmwan, OE	1
Alscher, DM; Berger, ED; Gugeler, N; Kirschner, T; Kuhlmann, U; Mettang, T; Mikus, G; Nagel, W; Pauli-Magnus, C; Risler, T	1
Ko, MC; Naughton, NN	1
Luger, TA; Metze, D; Reimann, S	1
Azar, R; Bah, S; Ballester, L; Brunet, C; Cazin, JC; Cazin, M; Dine, T; Gressier, B; Kambia, K; Luyckx, M; Odou, P	1
Inagaki, N; Kawasaki, H; Nagai, H; Nagao, M; Nakamura, N	1
Kaneko, M; Kawakita, T; Kuraishi, Y; Maekawa, T; Miyamoto, T; Nishikawa, Y; Nojima, H; Yamaguchi, T	1
Dello Buono, FA; Friedman, JD	1
Kamei, J; Nagase, H	1
Jones, EA; Neuberger, J	1
Bailey, SL; Faut-Callahan, M; Graves, J; Paice, JA; Pellegrini, JE; Shott, S	1
Ando, N; Endoh, T; Honda, T; Kamei, J; Kawamura, K; Nagase, H; Okano, K; Tanaka, T; Togashi, Y; Umeuchi, H; Utsumi, J; Yoshizawa, Y	1
Kuraishi, Y; Miyamoto, T; Nakahashi, T; Nojima, H; Shinkado, T	1
Bergasa, NV; Jones, EA	1
Abboud, TK; Afrasiabi, A; Chai, M; Lee, K; Mantilla, M; Reyes, A; Steffens, Z; Zhu, J	1
Harrison, PV	1
Monroe, EW	1
Burch, JR; Harrison, PV	1
Losowsky, MS; Thornton, JR	1
Court, MH; Dixon, R; Dodman, NH; Parker, D; Shuster, L; White, SD	1

Reviews

14 review(s) available for naltrexone and Pruritus

Article	Year
Naltrexone for cholestatic itch: a systematic review. BMJ supportive & palliative care, 2021, Volume: 11, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cholestasis; End Stage Liver Disease; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain; Pilot Projects; Pruritus; Research Design; Retrospective Studies	2021
Pruritus in Cutaneous T-Cell Lymphoma and Its Management. Dermatologic clinics, 2018, Volume: 36, Issue:3 Topics: Adrenal Cortex Hormones; Amines; Antidepressive Agents, Tricyclic; Antipruritics; Cyclohexanecarboxylic Acids; Emollients; Gabapentin; gamma-Aminobutyric Acid; Histamine Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Pruritus; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Visual Analog Scale	2018
The uses of naltrexone in dermatologic conditions. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:6 Topics: Administration, Oral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lichen Planus; Male; Naltrexone; Narcotic Antagonists; Patient Safety; Pemphigus, Benign Familial; Prognosis; Pruritus; Psoriasis; Risk Assessment; Skin Diseases; Treatment Outcome	2019
Naloxone and Maintenance Naltrexone as Novel and Effective Therapies for Immunotherapy-Induced Pruritus: A Case Report and Brief Literature Review. Journal of oncology practice, 2019, Volume: 15, Issue:6 Topics: Aged; Antibodies, Monoclonal, Humanized; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Immunotherapy; Naloxone; Naltrexone; Narcotic Antagonists; Prognosis; Pruritus; Rectal Neoplasms	2019
Uremic pruritus. Kidney international, 2015, Volume: 87, Issue:4 Topics: Acupuncture Therapy; Amines; Anti-Inflammatory Agents; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; gamma-Linolenic Acid; Humans; Morphinans; Naltrexone; Narcotic Antagonists; Pentoxifylline; Phototherapy; Pregabalin; Pruritus; Receptors, Opioid, kappa; Renal Insufficiency, Chronic; Spiro Compounds; Tacrolimus; Thalidomide; Uremia	2015
Targeting Itch with Ligands Selective for κ Opioid Receptors. Handbook of experimental pharmacology, 2015, Volume: 226 Topics: Animals; Dynorphins; Guanidines; Humans; Ligands; Mice; Morphinans; Naltrexone; p-Methoxy-N-methylphenethylamine; Peptide Fragments; Pruritus; Receptors, Opioid, kappa; Spiro Compounds	2015
Cholestatic Itch Management. Current problems in dermatology, 2016, Volume: 50 Topics: Anion Exchange Resins; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Humans; Lysophospholipids; Naltrexone; Narcotic Antagonists; Plasmapheresis; Pregnane X Receptor; Pruritus; Receptors, Steroid; Rifampin; Selective Serotonin Reuptake Inhibitors; Sertraline; Ultraviolet Therapy; Ursodeoxycholic Acid	2016
Antipruritic treatment with systemic μ-opioid receptor antagonists: a review. Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:4 Topics: Administration, Oral; Antipruritics; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Naloxone; Naltrexone; Pruritus; Randomized Controlled Trials as Topic; Receptors, Opioid, mu; Risk Assessment; Severity of Illness Index; Treatment Outcome	2010
Use of pure opioid antagonists for management of opioid-induced pruritus. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Aug-01, Volume: 68, Issue:15 Topics: Adult; Analgesics, Opioid; Child; Humans; Infusions, Intravenous; Naloxone; Naltrexone; Narcotic Antagonists; Pruritus; Quality of Life; Quaternary Ammonium Compounds	2011
Uraemic pruritus--new perspectives and insights from recent trials. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:9 Topics: Humans; Naltrexone; Peritoneal Dialysis, Continuous Ambulatory; Prevalence; Pruritus; Renal Dialysis; Tacrolimus; Uremia	2002
Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:12 Topics: Adult; Aged; Antipruritics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Naltrexone; Probability; Pruritus; Receptors, Opioid, kappa; Reference Values; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Uremia	2005
Naltrexone: a case report of pruritus from an antipruritic. The Australasian journal of dermatology, 1997, Volume: 38, Issue:4 Topics: Female; Humans; Injections, Subcutaneous; Middle Aged; Mycosis Fungoides; Naloxone; Naltrexone; Narcotic Antagonists; Pruritus; Skin Neoplasms	1997
Recent studies of cutaneous nociception in atopic and non-atopic subjects. The Journal of dermatology, 1999, Volume: 26, Issue:2 Topics: Acetylcholine; Dermatitis, Atopic; Eczema; Histamine; Humans; Naltrexone; Nociceptors; Pruritus; Psoriasis; Skin; Urticaria	1999
Opioid antagonists in the treatment of opioid-induced constipation and pruritus. The Annals of pharmacotherapy, 2001, Volume: 35, Issue:1 Topics: Clinical Trials as Topic; Constipation; Humans; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pruritus; Quaternary Ammonium Compounds	2001

Trials

25 trial(s) available for naltrexone and Pruritus

Article	Year
Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial. British journal of anaesthesia, 2015, Volume: 114, Issue:3 Topics: Adult; Analgesia, Obstetrical; Analgesics, Opioid; Anesthesia, Spinal; Australia; Cesarean Section; Female; Humans; Middle Aged; Morphine; Naltrexone; Narcotic Antagonists; Postoperative Complications; Pregnancy; Pruritus; Quaternary Ammonium Compounds; Singapore; Treatment Outcome; United States; Young Adult	2015
Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dermatitis, Atopic; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Pain Measurement; Pruritus; Treatment Outcome	2009
A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic derm Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:8 Topics: Administration, Cutaneous; Administration, Topical; Adult; Antipruritics; Cross-Over Studies; Delayed-Action Preparations; Dermatitis, Atopic; Double-Blind Method; Drug Evaluation; Electronic Health Records; Emollients; Female; Humans; Intention to Treat Analysis; Male; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid; Treatment Outcome	2011
Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema. Experimental dermatology, 2002, Volume: 11, Issue:5 Topics: Acetylcholine; Adult; Blood Flow Velocity; Dermatitis, Atopic; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nociceptors; Physical Stimulation; Pruritus; Skin	2002
Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. Journal of hepatology, 2002, Volume: 37, Issue:6 Topics: Administration, Oral; Adult; Aged; Cholestasis; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Safety	2002
A comparative study on the effects of naltrexone and loratadine on uremic pruritus. Dermatology (Basel, Switzerland), 2004, Volume: 208, Issue:4 Topics: Antipruritics; Drug Administration Schedule; Female; Humans; Loratadine; Male; Middle Aged; Naltrexone; Pruritus; Surveys and Questionnaires; Treatment Outcome; Uremia	2004
[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:12 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Pruritus; Tachyphylaxis; Treatment Outcome	2004
Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching. International journal of dermatology, 2004, Volume: 43, Issue:12 Topics: Administration, Oral; Adult; Animals; Antimalarials; Antipruritics; Area Under Curve; Chloroquine; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Naltrexone; Opioid Peptides; Parasitemia; Plasmodium; Promethazine; Pruritus; Receptors, Opioid, mu; Time Factors	2004
Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:12 Topics: Adult; Aged; Antipruritics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Naltrexone; Probability; Pruritus; Receptors, Opioid, kappa; Reference Values; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Uremia	2005
Effect of oral naltrexone on pruritus in cholestatic patients. World journal of gastroenterology, 2006, Feb-21, Volume: 12, Issue:7 Topics: Administration, Oral; Adult; Aged; Cholestasis; Dizziness; Headache; Humans; Middle Aged; Muscle Weakness; Naltrexone; Nausea; Pain Measurement; Placebos; Pruritus; Single-Blind Method; Substance Withdrawal Syndrome; Surveys and Questionnaires	2006
Treatment of pruritus with topically applied opiate receptor antagonist. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:6 Topics: Administration, Topical; Adult; Aged; Cross-Over Studies; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Male; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Pilot Projects; Prospective Payment System; Pruritus	2007
Randomised crossover trial of naltrexone in uraemic pruritus. Lancet (London, England), 1996, Dec-07, Volume: 348, Issue:9041 Topics: beta-Endorphin; Cross-Over Studies; Double-Blind Method; Histamine; Humans; Naltrexone; Narcotic Antagonists; Pruritus; Renal Dialysis; Uremia	1996
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology, 1997, Volume: 113, Issue:4 Topics: Administration, Oral; Adult; Aged; Cholangitis, Sclerosing; Cholestasis; Double-Blind Method; Fatigue; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Pruritus	1997
Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis. Pain, 1997, Volume: 73, Issue:2 Topics: Adult; Cross-Over Studies; Dermatitis, Atopic; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Iontophoresis; Male; Naltrexone; Narcotic Antagonists; Pruritus; Reference Values	1997
Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology (Baltimore, Md.), 1998, Volume: 27, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Cholestasis; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Pruritus	1998
Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia. Anesthesiology, 1999, Volume: 90, Issue:4 Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Morphine; Naltrexone; Narcotic Antagonists; Nausea; Postoperative Complications; Pruritus; Vomiting	1999
Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. Journal of the American Academy of Dermatology, 1999, Volume: 41, Issue:3 Pt 1 Topics: Administration, Oral; Adult; Antipruritics; Cholestasis; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Tablets; Time Factors	1999
Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. Journal of the American Academy of Dermatology, 1999, Volume: 41, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Pruritus	1999
Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cohort Studies; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Peritoneal Dialysis; Placebos; Pruritus; Renal Dialysis; Treatment Failure; Uremia	2000
Effective treatment of pruritus with naltrexone, an orally active opiate antagonist. Annals of the New York Academy of Sciences, 1999, Oct-20, Volume: 885 Topics: Administration, Oral; Humans; Naltrexone; Narcotic Antagonists; Pilot Projects; Pruritus; Treatment Outcome	1999
The impact of nalmefene on side effects due to intrathecal morphine at cesarean section. AANA journal, 2001, Volume: 69, Issue:3 Topics: Adult; Analgesia, Epidural; Analgesics, Opioid; Cesarean Section; Double-Blind Method; Female; Humans; Morphine; Naltrexone; Narcotic Antagonists; Pain, Postoperative; Postoperative Complications; Postoperative Nausea and Vomiting; Pregnancy; Pruritus; Statistics, Nonparametric; Survival Analysis; Time Factors	2001
Prophylactic oral naltrexone with intrathecal morphine for cesarean section: effects on adverse reactions and analgesia. Anesthesia and analgesia, 1990, Volume: 71, Issue:4 Topics: Administration, Oral; Adult; Cesarean Section; Double-Blind Method; Female; Humans; Injections, Spinal; Morphine; Naltrexone; Nausea; Pain, Postoperative; Pregnancy; Pruritus; Randomized Controlled Trials as Topic; Sleep	1990
Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. Journal of the American Academy of Dermatology, 1989, Volume: 21, Issue:1 Topics: Chronic Disease; Dermatitis, Atopic; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Placebos; Pruritus; Random Allocation; Urticaria	1989
Opiates, sleep and itch. Clinical and experimental dermatology, 1988, Volume: 13, Issue:6 Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Naltrexone; Pruritus; Sleep Wake Disorders	1988
Opioid peptides and primary biliary cirrhosis. BMJ (Clinical research ed.), 1988, Dec-10, Volume: 297, Issue:6662 Topics: Adult; Aged; Bilirubin; Fatigue; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pruritus; Substance Withdrawal Syndrome	1988

Other Studies

60 other study(ies) available for naltrexone and Pruritus

Article	Year
Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic. Molecules (Basel, Switzerland), 2021, Sep-11, Volume: 26, Issue:18 Topics: Animals; Antipruritics; Behavior, Animal; Chloroquine; Deoxycholic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Nalbuphine; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid, kappa; tat Gene Products, Human Immunodeficiency Virus	2021
Prurigo excoriée treated with low dose naltrexone. BMJ case reports, 2021, Nov-19, Volume: 14, Issue:11 Topics: Female; Humans; Isotretinoin; Middle Aged; Naltrexone; Prurigo; Pruritus; Quality of Life	2021
Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias? Dermatology online journal, 2019, Aug-15, Volume: 25, Issue:8 Topics: Alopecia; Humans; Naltrexone; Narcotic Antagonists; Pain; Paresthesia; Pruritus; Scalp Dermatoses	2019
β2-Microglobulin elicits itch-related responses in mice through the direct activation of primary afferent neurons expressing transient receptor potential vanilloid 1. European journal of pharmacology, 2017, Sep-05, Volume: 810 Topics: Animals; Behavior, Animal; beta 2-Microglobulin; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Male; Mice; Naltrexone; Neurons, Afferent; Phosphorylation; Pruritus; TRPV Cation Channels	2017
Attenuation of serotonin-induced itch by sumatriptan: possible involvement of endogenous opioids. Archives of dermatological research, 2018, Volume: 310, Issue:2 Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Humans; Injections, Intradermal; Male; Mice; Naltrexone; Narcotic Antagonists; Opioid Peptides; Oxadiazoles; Piperazines; Pruritus; Quaternary Ammonium Compounds; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Sumatriptan	2018
The Use of Naltrexone in Dermatology. Current Evidence and Future Directions. Current drug targets, 2019, Volume: 20, Issue:10 Topics: Cytokines; Dose-Response Relationship, Drug; Humans; Immunomodulation; Naltrexone; Pruritus; Signal Transduction; Skin Diseases; T-Lymphocytes; Toll-Like Receptors; Trichotillomania	2019
Cross-talk between Human Spinal Cord μ-opioid Receptor 1Y Isoform and Gastrin-releasing Peptide Receptor Mediates Opioid-induced Scratching Behavior. Anesthesiology, 2019, Volume: 131, Issue:2 Topics: Aged; Analgesics, Opioid; Animals; Behavior, Animal; Cadaver; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred C57BL; Morphine; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Bombesin; Receptors, Opioid, mu; Spinal Cord	2019
Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice. Neuroscience letters, 2014, Mar-20, Volume: 563 Topics: Animals; Benzeneacetamides; Dose-Response Relationship, Drug; Dynorphins; Injections, Subcutaneous; Male; Mice; Mice, Knockout; Naltrexone; Peptide Fragments; Pruritus; Pyrrolidines; Radioligand Assay; Receptors, Opioid, kappa	2014
[Therapy of prurigo nodularis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2014, Volume: 65, Issue:8 Topics: Anticonvulsants; Antidepressive Agents; Dermatologic Agents; Dermatology; Evidence-Based Medicine; Germany; Humans; Naltrexone; Practice Guidelines as Topic; Prurigo; Pruritus	2014
Cerebral Networks Linked to Itch-related Sensations Induced by Histamine and Capsaicin. Acta dermato-venereologica, 2015, Volume: 95, Issue:6 Topics: Adolescent; Adult; Amygdala; Brain Mapping; Capsaicin; Caudate Nucleus; Cerebral Cortex; Cross-Over Studies; Double-Blind Method; Functional Neuroimaging; Hippocampus; Histamine; Humans; Magnetic Resonance Imaging; Male; Naltrexone; Narcotic Antagonists; Paresthesia; Pruritus; Putamen; Random Allocation; Sensation; Skin Physiological Phenomena; Young Adult	2015
Metastatic hepatocellular carcinoma with paraneoplastic itch: effective treatment with naltrexone. Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:12 Topics: Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Neoplasm Metastasis; Paraneoplastic Syndromes; Pruritus; Treatment Outcome	2014
Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease. Journal of palliative care, 2015, Volume: 31, Issue:2 Topics: Aged; Carcinoma, Hepatocellular; Fatal Outcome; Female; Gallbladder Neoplasms; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Quaternary Ammonium Compounds; Terminal Care	2015
Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus. Neuropharmacology, 2015, Volume: 99 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Arrestins; beta-Arrestins; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Guanidines; Isoquinolines; Male; Mice, Inbred C57BL; Mice, Knockout; Morphinans; Motor Activity; Naltrexone; Pruritus; Receptors, Opioid, kappa	2015
Involvement of the BLT2 receptor in the itch-associated scratching induced by 12-(S)-lipoxygenase products in ICR mice. British journal of pharmacology, 2008, Volume: 154, Issue:5 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Antipruritics; Arachidonate 12-Lipoxygenase; Behavior, Animal; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fatty Alcohols; Glycols; Male; Mice; Mice, Inbred ICR; Naltrexone; Pruritus; Receptors, Leukotriene B4; Signal Transduction; Tetrazoles; Video Recording	2008
Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:9 Topics: Alfentanil; Analgesics, Opioid; Animals; Behavior, Animal; Benzimidazoles; Capsaicin; Central Nervous System Agents; Dose-Response Relationship, Drug; Female; Hot Temperature; Imidazoles; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Nociceptin Receptor; Pain; Piperidines; Pruritus; Receptors, Opioid; Receptors, Opioid, mu; Reinforcement, Psychology; Respiratory Insufficiency; Spiro Compounds	2009
Scratching behavior and Fos expression in superficial dorsal horn elicited by protease-activated receptor agonists and other itch mediators in mice. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:3 Topics: Animals; Behavior, Animal; Capsaicin; Histamine; Injections, Intradermal; Mice; Morphine; Naltrexone; Oligopeptides; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pruritus; Receptor, PAR-2; Receptors, Opioid, mu; Receptors, Proteinase-Activated; Serotonin; Spinal Cord; Tachyphylaxis	2009
Ethanol aggravates itch-related scratching in hairless mice developing atopic dermatitis. European journal of pharmacology, 2009, Jun-02, Volume: 611, Issue:1-3 Topics: Administration, Oral; Animals; Capsaicin; Dermatitis, Atopic; Dibucaine; Ethanol; Female; Mice; Mice, Hairless; N-Methylaspartate; Naltrexone; Petrolatum; Pruritus; Skin Temperature	2009
Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice. Neuroscience, 2009, Sep-29, Volume: 163, Issue:1 Topics: Afferent Pathways; Analgesics, Opioid; Animals; Antipruritics; Biomarkers; Disease Models, Animal; Guanidines; Male; Mice; Morphinans; Naltrexone; Narcotic Antagonists; Nociceptors; p-Methoxy-N-methylphenethylamine; Pain Measurement; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pruritus; Receptors, Opioid, kappa; Sensory Receptor Cells; Spinal Cord; Spiro Compounds; Treatment Outcome	2009
Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence. European journal of pharmacology, 2009, Aug-15, Volume: 616, Issue:1-3 Topics: Animals; Behavior, Animal; Formaldehyde; Gene Expression Regulation; Guanidines; Lidocaine; Male; Mice; Morphinans; Naltrexone; Neurons; Pain; Proto-Oncogene Proteins c-fos; Pruritus; Receptors, Opioid, kappa	2009
Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin. The Journal of investigative dermatology, 2009, Volume: 129, Issue:12 Topics: Animals; Calcium; Dermatitis, Atopic; Ganglia, Spinal; Histamine; Histamine H1 Antagonists, Non-Sedating; Injections, Intradermal; Keratinocytes; Leukotriene B4; Male; Mast Cells; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Neurons; Phosphorylcholine; Pruritus; Skin; Sphingomyelins; Sphingosine; Terfenadine	2009
Spontaneous itch in the absence of hyperalgesia in a mouse hindpaw dry skin model. Neuroscience letters, 2010, Oct-22, Volume: 484, Issue:1 Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Hindlimb; Hyperalgesia; Male; Mice; Morphine; Naltrexone; Pain Measurement; Pruritus; Skin	2010
Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. Journal of pediatric gastroenterology and nutrition, 2010, Volume: 51, Issue:6 Topics: Administration, Oral; Adolescent; Alagille Syndrome; Antipruritics; Child; Child, Preschool; Cholangitis, Sclerosing; Cholestasis; Female; Humans; Naltrexone; Pruritus	2010
Differential itch- and pain-related behavioral responses and µ-opoid modulation in mice. Acta dermato-venereologica, 2010, Volume: 90, Issue:6 Topics: Analgesics, Opioid; Animals; Antigens, Plant; Behavior, Animal; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Histamine; Injections, Intradermal; Irritants; Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Mucuna; Naltrexone; Narcotic Antagonists; Pain; Pruritus; Receptor, PAR-2; Receptors, Opioid, mu; Receptors, Thrombin; Time Factors	2010
Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice. Peptides, 2011, Volume: 32, Issue:2 Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Bombesin; Compulsive Behavior; Ganglia, Spinal; Gastrin-Releasing Peptide; Grooming; Guanidines; Locomotion; Male; Mice; Morphinans; Naltrexone; Nerve Fibers; Peptide Fragments; Pirenzepine; Pruritus; Receptor, Muscarinic M1; Receptors, Bombesin; Receptors, Opioid, kappa; Skin; Spinal Cord; Spiro Compounds	2011
Pruritus responsive to naltrexone in a patient with cholestatic liver disease. The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:2 Topics: Alagille Syndrome; Child, Preschool; Female; Humans; Naltrexone; Narcotic Antagonists; Pruritus	2011
Inhibition of itch-related responses at spinal level in rats. Acta physiologica Hungarica, 2011, Volume: 98, Issue:4 Topics: 5-Methoxytryptamine; Analgesics; Animals; Behavior, Animal; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Injections, Spinal; Ketamine; Kynurenic Acid; Male; Naltrexone; Narcotic Antagonists; Pruritus; Rats; Rats, Wistar; Spinal Cord	2011
Mouse model of touch-evoked itch (alloknesis). The Journal of investigative dermatology, 2012, Volume: 132, Issue:7 Topics: Animals; Disease Models, Animal; Histamine; Mice; Mice, Inbred C57BL; Naltrexone; Oligopeptides; Peptide Fragments; Pruritus; Receptors, Thrombin; Touch	2012
Opioid modulation of facial itch- and pain-related responses and grooming behavior in rats. Acta dermato-venereologica, 2012, Volume: 92, Issue:5 Topics: Analgesics, Opioid; Animals; Antipruritics; Disease Models, Animal; Face; Grooming; Injections, Intradermal; Male; Morphine; Mustard Plant; Naltrexone; Narcotic Antagonists; Pain; Plant Oils; Pruritus; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors	2012
Cathepsin E induces itch-related response through the production of endothelin-1 in mice. European journal of pharmacology, 2012, Jul-05, Volume: 686, Issue:1-3 Topics: Animals; Behavior, Animal; Cathepsin E; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Histamine Release; Keratinocytes; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Pepstatins; Peptides, Cyclic; Protease Inhibitors; Pruritus; Receptor, PAR-2; RNA, Messenger; Skin	2012
Effects of acute stressors on itch- and pain-related behaviors in rats. Pain, 2012, Volume: 153, Issue:9 Topics: Animals; Behavior, Animal; Grooming; Injections, Intradermal; Irritants; Isothiocyanates; Male; Naltrexone; Narcotic Antagonists; Nociception; Pain; Pruritus; Rats; Rats, Sprague-Dawley; Serotonin; Stress, Psychological	2012
Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease. Journal of palliative medicine, 2013, Volume: 16, Issue:2 Topics: Aged, 80 and over; Cholestasis; Comorbidity; Humans; Male; Naloxone; Naltrexone; Narcotic Antagonists; Pruritus; Quality of Life; Quaternary Ammonium Compounds	2013
Effects of naltrexone on spontaneous itch-associated responses in NC mice with chronic dermatitis. Japanese journal of pharmacology, 2002, Volume: 90, Issue:2 Topics: Animals; Behavior, Animal; Chronic Disease; Dermatitis, Atopic; Female; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Naltrexone; Narcotic Antagonists; Pruritus; Skin	2002
Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Disease Models, Animal; Drug Interactions; Female; Injections, Spinal; Injections, Subcutaneous; Macaca mulatta; Male; Morphine; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid, kappa	2003
Quantitative assessment of directed hind limb scratching behavior as a rodent itch model. Journal of neuroscience methods, 2003, Jun-30, Volume: 126, Issue:2 Topics: Animals; Behavior, Animal; Disease Models, Animal; Hindlimb; Injections, Intradermal; Male; Naltrexone; Narcotic Antagonists; Pruritus; Rats; Rats, Sprague-Dawley; Reflex; Serotonin	2003
Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. European journal of pharmacology, 2003, Sep-05, Volume: 477, Issue:1 Topics: Animals; Antipruritics; Behavior, Animal; Injections, Intraventricular; Injections, Subcutaneous; Ketotifen; Male; Mice; Morphinans; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spiro Compounds; Substance P	2003
Opioid modulation of scratching and spinal c-fos expression evoked by intradermal serotonin. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003, Nov-26, Volume: 23, Issue:34 Topics: Analgesics, Opioid; Animals; Behavior, Animal; Hindlimb; Injections, Intradermal; Male; Microinjections; Morphine; Naltrexone; Narcotic Antagonists; Neck; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pruritus; Rats; Rats, Sprague-Dawley; Serotonin; Spinal Cord	2003
Effective opiate-receptor antagonist therapy of cholestatic pruritus induced by an oral contraceptive. Journal of pediatric gastroenterology and nutrition, 2005, Volume: 40, Issue:5 Topics: Administration, Oral; Adolescent; Cholestasis, Intrahepatic; Contraceptives, Oral, Combined; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Naltrexone; Narcotic Antagonists; Pruritus; Treatment Outcome	2005
Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride. European journal of pharmacology, 2005, Aug-22, Volume: 518, Issue:2-3 Topics: Age Factors; Animals; Antipruritics; Autoimmune Diseases; Behavior, Animal; Chlorpheniramine; Dermis; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Immunoglobulin E; Immunoglobulin G; Male; Mice; Mice, Inbred ICR; Mice, Inbred MRL lpr; Mice, Inbred Strains; Morphinans; Naltrexone; Pruritus; Receptors, Opioid, kappa; Sex Factors; Spiro Compounds	2005
[Antipuritic therapy with naltrexone]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2005, Volume: 56, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Pruritus; Tachyphylaxis; Treatment Outcome	2005
Successful treatment of refractory aquagenic pruritus with naltrexone. Journal of cutaneous medicine and surgery, 2005, Volume: 9, Issue:5 Topics: Antipruritics; Baths; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Pruritus; Time Factors; Treatment Outcome; Water	2005
12(S)-HPETE induces itch-associated scratchings in mice. European journal of pharmacology, 2007, Jan-05, Volume: 554, Issue:1 Topics: Animals; Capsaicin; Dose-Response Relationship, Drug; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred ICR; Naltrexone; Pruritus; Receptors, Leukotriene B4	2007
Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632. European journal of pharmacology, 2008, Mar-31, Volume: 583, Issue:1 Topics: Amides; Animals; Antipruritics; Behavior, Animal; Capsaicin; Dose-Response Relationship, Drug; Injections, Intradermal; Ketotifen; Male; Mice; Mice, Inbred ICR; Muscle Relaxants, Central; Naltrexone; Narcotic Antagonists; Phosphorylcholine; Pruritus; Pyridines; rho-Associated Kinases; Sphingosine	2008
Naltrexone for the management of post-burn pruritus: A preliminary report. Burns : journal of the International Society for Burn Injuries, 2008, Volume: 34, Issue:6 Topics: Adult; Aged; Antipruritics; Burns; Canada; Case-Control Studies; Female; Humans; Male; Middle Aged; Naltrexone; Pruritus; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome	2008
Naltrexone-induced pruritus in a dog with tail-chasing behavior. Journal of the American Veterinary Medical Association, 1993, Jan-15, Volume: 202, Issue:2 Topics: Animals; Behavior, Animal; Dog Diseases; Dogs; Male; Naltrexone; Pruritus; Self Mutilation; Stereotyped Behavior	1993
Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease. The American journal of gastroenterology, 1996, Volume: 91, Issue:5 Topics: Antipruritics; Cholestasis, Intrahepatic; Humans; Naltrexone; Pilot Projects; Pruritus; Quality of Life; Treatment Outcome	1996
[Opiod antagonists and treatment of cholestatic pruritus]. Gastroenterologie clinique et biologique, 1998, Volume: 22, Issue:2 Topics: Cholestasis; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Placebos; Pruritus; Randomized Controlled Trials as Topic	1998
Itching for relief. Health news (Waltham, Mass.), 1999, Dec-15, Volume: 5, Issue:15 Topics: Drug Tolerance; Humans; Naltrexone; Narcotic Antagonists; Pruritus	1999
Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. Gastroenterology, 2000, Volume: 118, Issue:2 Topics: Administration, Oral; Adult; Cholestasis; Chronic Disease; Female; Humans; Infusions, Intravenous; Naltrexone; Narcotic Antagonists; Pruritus; Substance Withdrawal Syndrome	2000
Mechanisms of chloroquine-induced body-scratching behavior in rats: evidence of involvement of endogenous opioid peptides. Pharmacology, biochemistry, and behavior, 2000, Volume: 65, Issue:2 Topics: Animals; Antimalarials; Chloroquine; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Opioid Peptides; Pruritus; Rats	2000
An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception. Anesthesiology, 2000, Volume: 92, Issue:3 Topics: Analgesics, Opioid; Animals; Antipruritics; Dose-Response Relationship, Drug; Female; Hot Temperature; Injections, Spinal; Macaca mulatta; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Pruritus; Receptors, Opioid	2000
High-performance liquid chromatographic determination of naltrexone in plasma of hemodialysis patients. Biomedical chromatography : BMC, 2000, Volume: 14, Issue:3 Topics: Chromatography, High Pressure Liquid; Humans; Kidney Failure, Chronic; Naltrexone; Narcotic Antagonists; Pruritus; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity	2000
Inhibition of passive cutaneous anaphylaxis-associated scratching behavior by mu-opioid receptor antagonists in ICR mice. International archives of allergy and immunology, 2000, Volume: 123, Issue:4 Topics: Animals; Behavior, Animal; Capillary Permeability; Female; Histamine; Humans; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; p-Methoxy-N-methylphenethylamine; Passive Cutaneous Anaphylaxis; Pruritus; Receptors, Opioid, mu	2000
Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. Journal of dermatological science, 2001, Volume: 25, Issue:1 Topics: Animals; Attention; Chronic Disease; Dermatitis; Female; Histamine; Immunoglobulin E; Mice; Mice, Inbred Strains; Mites; Naltrexone; Narcotic Antagonists; Pruritus; Serotonin; Substance P	2001
Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. European journal of pharmacology, 2001, Apr-20, Volume: 418, Issue:1-2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Antipruritics; Behavior, Animal; Chlorpheniramine; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Injections, Subcutaneous; Mice; Mice, Inbred ICR; Naltrexone; p-Methoxy-N-methylphenethylamine; Pruritus; Receptors, Opioid, kappa	2001
Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy. European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:11 Topics: Contraindications; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Naltrexone; Narcotic Antagonists; Pruritus	2001
Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. European journal of pharmacology, 2002, Jan-25, Volume: 435, Issue:2-3 Topics: Animals; Antipruritics; Chlorpheniramine; Disease Models, Animal; Histamine; Histamine H1 Antagonists; Ketotifen; Male; Mice; Mice, Inbred ICR; Morphinans; Motor Activity; Naltrexone; Pruritus; Receptors, Opioid, kappa; Spiro Compounds; Substance P	2002
Itch-associated response induced by experimental dry skin in mice. Japanese journal of pharmacology, 2002, Volume: 88, Issue:3 Topics: Animals; Behavior, Animal; Blood-Air Barrier; Male; Mast Cells; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Pruritus; Skin; Skin Diseases; Water Loss, Insensible	2002
The pruritus of cholestasis and the opioid system. JAMA, 1992, Dec-16, Volume: 268, Issue:23 Topics: Cholangitis, Sclerosing; Female; Humans; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid	1992
Nalmefene and pruritus. Journal of the American Academy of Dermatology, 1990, Volume: 23, Issue:3 Pt 1 Topics: Humans; Naltrexone; Pruritus; Random Allocation	1990
Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs. Journal of the American Veterinary Medical Association, 1988, Oct-01, Volume: 193, Issue:7 Topics: Animals; Behavior, Animal; Dog Diseases; Dogs; Injections, Subcutaneous; Naltrexone; Narcotic Antagonists; Pruritus	1988